U.S. Pharma Stock News

If you are wondering whether Rithm Capital’s current share price reflects its true worth, you are not alone, especially with income focused financial stocks back on many watchlists. The stock last closed at US$9.87, with returns of 1.1% over 7 days but declines of 7.3% over 30 days, 10.1% year to date, and 5.7% over 1 year. However, the 3 year and 5 year returns of 64.6% and 41.6% show a very different picture for longer term holders. Recent coverage has focused on Rithm Capital’s position...

What FuelCell Energy’s Latest Earnings Tell You FuelCell Energy (FCEL) just reported Q1 2026 results, with revenue of US$30.53 million, sales of US$10.99 million, and a net loss of US$22.86 million, alongside a smaller loss per share year over year. See our latest analysis for FuelCell Energy. FuelCell Energy’s shares have been under pressure despite the Q1 2026 revenue lift and narrower loss. The 7 day share price return shows a 17.04% decline and the 90 day share price return shows an...

Blend Labs (BLND) just posted its FY 2025 fourth quarter numbers, with revenue of US$32.4 million and a basic EPS loss of US$0.03, while net income excluding extra items came in at a loss of US$7.1 million. The company has seen quarterly revenue move from US$41.4 million in Q4 2024 to US$32.4 million in Q4 2025, with basic EPS shifting from a loss of US$0.03 in Q4 2024 to a loss of US$0.03 in the latest quarter. As a result, this reporting period is likely to draw attention to how the loss...

If you are wondering whether Costamare's current share price offers value or risk, this article walks through what the numbers actually say about the stock. Over the past year, Costamare's share price return stands at 126.4%, with a 7.1% return year to date and 4.4% over the last 30 days, while the most recent 7 day period shows a 3.7% decline. Recent news around shipping, charter rates, and trade flows has kept attention on container ship and dry bulk owners. This has put companies like...

If you are wondering whether Qualys shares are starting to look interesting, this article will walk through how the current price lines up against the underlying business. The stock last closed at US$96.66, with returns of a 1.4% decline over 7 days, an 11.4% decline over 30 days, a 26.2% decline year to date, and a 21.5% decline over the past year, which may influence how investors are thinking about both growth potential and risk. Over the past few months, Qualys has continued to feature...

If you are wondering whether Fabrinet's recent share price puts it on your watchlist or on the too-expensive pile, it helps to first pin down what you are actually paying for today. The stock last closed at US$524.33, after a 7 day return of a 7.0% decline, a 30 day return of 4.5%, a year to date return of 9.4% and a 1 year return of 159.7%, with the 3 year return at 362.2% and the 5 year figure very large compared to the starting point. Recent price moves have been accompanied by ongoing...

If you are wondering whether Strategic Education's current share price still represents solid value, the recent data gives you plenty to think about. The stock closed at US$78.87 recently, with returns of a 3.3% decline over 7 days and a 1.3% decline over 30 days, while year to date it is up 0.4% and the 1-year return sits at 1.6%. These steady but modest return figures over the past year, including 0.8% over 3 years and 4.6% over 5 years, suggest the market has been cautious in how it...

Elevance Health (NYSE:ELV) has signed new network participation agreements with Myomo, Inc. The deals extend in-network coverage for Myomo’s FDA cleared orthopedic devices to Elevance’s roughly 45 million Commercial, Medicare Advantage, and Medicaid members nationwide. For you as an investor, this ties directly into how NYSE:ELV positions itself as a broad based health benefits and services company. Elevance already spans commercial employer plans, government programs, and related health...

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...

Transocean has completed an all stock acquisition of Valaris, combining two major offshore drilling companies. The deal significantly expands Transocean's offshore rig fleet and contract portfolio. Management expects cost synergies and a stronger competitive position in the global offshore drilling market. For investors watching NYSE:RIG, this merger follows a period of strong share price moves, with the stock up 48.8% year to date and 111.7% over the past year, closing at $6.31. The...

If you are wondering whether Preformed Line Products is still offering value after a strong run, this article walks through what the current share price might be implying about the business. The stock closed at US$267.23 recently, with returns of 4.6% over 7 days, a 2.5% decline over 30 days, 26.1% year to date and 118.3% over the past year, as well as 135.3% over 3 years and 271.3% over 5 years. Recent attention on grid reliability, utility infrastructure and related capital projects has...

Wells Fargo has filed a trademark application for "WFUSD," indicating potential plans to offer digital asset and cryptocurrency services. The filing points to possible products such as crypto trading, exchange services, payment processing, and digital asset wallets. This move would represent an expansion of Wells Fargo's role in the growing crypto and blockchain segment of financial services. Shares of Wells Fargo (NYSE:WFC) last closed at $76.88, with the stock showing a 14.0% return over...

Lantronix (LTRX) is back on investor radars after expanding its embedded compute portfolio with new MediaTek based System on Module solutions and signing a European distribution deal with Melchioni Electronics. See our latest analysis for Lantronix. The recent MediaTek based SOM launch and the Melchioni distribution deal arrive after a mixed stretch for the stock, with a 7 day share price return of 3.89% but a 90 day share price return decline of 6.69%, while the 1 year total shareholder...

uniQure (NasdaqGS:QURE) faces multiple securities class action lawsuits focused on disclosures around its AMT-130 gene therapy program. Federal health officials have criticized the company for alleged data manipulation tied to AMT-130. The FDA has withdrawn support for a Biologics License Application for AMT-130, complicating the program's regulatory path. Upcoming changes in FDA leadership are expected to affect how AMT-130 and related filings are reviewed. These developments arrive at a...

If you are wondering whether Amdocs is starting to look like value after a weaker share price, this article will help you weigh what the current price actually offers you. The stock last closed at US$66.92, with returns of a 2.6% decline over 7 days, an 8.8% decline over 30 days, a 16.5% decline year to date, and a 21.6% decline over the past year. Recent coverage around Amdocs has focused on its role as a software and services provider to telecom and media companies. This keeps attention on...

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...

If you are wondering whether Microchip Technology is still good value after its recent run, this article will walk through what the current share price could mean for long term investors. The stock trades at US$65.79, with recent returns showing a 5.9% decline over 7 days, an 11.6% decline over 30 days, but a 30.6% gain over the past year and a 1.2% return year to date. Recent coverage around Microchip Technology has focused on its position in the semiconductor space and how investor...

Domo (DOMO) closed FY 2026 with fourth quarter revenue of US$79.6 million and a basic EPS loss of US$0.19, setting a clear snapshot of where the top line and bottom line currently stand. Over recent periods the company has kept quarterly revenue in a tight band around US$79 million to US$80 million, while basic EPS losses have ranged from US$0.25 to US$0.56 per quarter, giving investors a consistent read on how revenue scale and per share losses are tracking together. With that backdrop, this...

Afya: Stock Performance Snapshot After Recent Moves Afya (NasdaqGS:AFYA) has seen mixed share performance recently, with a 1-day return of about a 1% decline, a 3.3% gain over the past week, and weaker results over the past month and the past 3 months. See our latest analysis for Afya. With the share price at $13.88, Afya’s recent 7 day share price return of about 3% contrasts with weaker 1 month and year to date share price returns. Its 3 year total shareholder return of roughly 30% still...

If you are wondering whether FIGS is still good value after its recent run or if it is starting to look stretched, this article will walk through what the current price actually implies. FIGS trades at US$15.70 after a 46.2% return over the last 30 days, with year-to-date gains of 37.8% and a 1-year return of 237.6%, although the stock has slipped 7.5% over the past week. Recent market attention has centered on FIGS as investors reassess its position in the consumer durables space and...

HCA Healthcare (NYSE:HCA) has received the 2026 Patient Safety Excellence Award from Healthgrades for 92 of its hospitals. The recognition highlights strong performance on patient safety and quality metrics across a wide portion of HCA’s hospital network. This award follows earlier 2026 acknowledgments for several HCA facilities as top performers for quality and safety in the US hospital market. HCA Healthcare operates a large network of hospitals and outpatient facilities across the US, so...

Transaction Systems Services (TSS) closed its FY 2025 third quarter with revenue of US$41.9 million, Basic EPS of US$0.06 loss and net income excluding extra items of US$1.5 million loss. The trailing twelve months show revenue of US$234.8 million, Basic EPS of US$0.20 and net income of US$4.9 million. Over recent periods, the company has seen quarterly revenue move between US$12.2 million and US$99.0 million, with Basic EPS ranging from US$0.06 loss to US$0.13 per share. Net income excluding...

Pangaea Logistics Solutions (PANL) just wrapped up FY 2025 with fourth quarter revenue of US$183.9 million and basic EPS of US$0.19, alongside net income of US$11.9 million, in a context where trailing twelve month revenue is US$632.0 million and EPS is US$0.30. Over recent periods, the company’s quarterly revenue moved from US$147.2 million in Q4 2024 to US$183.9 million in Q4 2025. Over the same quarters, basic EPS shifted from US$0.18 to US$0.19. Investors may weigh these changes in...

Tidewater Inc. has reported its fourth quarter and full-year 2025 results, with Q4 revenue of US$336.8 million and a sharp increase in net income to US$219.88 million, alongside full-year revenue of US$1.35 billion and net income of US$334.66 million. Alongside these results, the company issued 2026 revenue guidance of US$1.43–US$1.48 billion, signaling management’s expectations for higher activity levels across its offshore support operations. Now we’ll examine how Tidewater’s stronger 2025...